Google DeepMind Releases AlphaGenome Atlas With Precomputed Molecular Effect Predictions and AVI Scores for 9 Billion Human DNA Variants
Google DeepMind launched AlphaGenome Atlas, precomputing molecular effect predictions and AVI impact scores for ~9 billion human single-nucleotide variants in a 1-petabyte catalogue.
Google DeepMind released AlphaGenome Atlas, a 1-petabyte catalogue of precomputed molecular effect predictions for roughly 9 billion possible single-nucleotide variants in the human genome. It introduces the AlphaGenome Variant Impact (AVI) score, combining AlphaGenome regulatory predictions with AlphaMissense, plus per-variant feature attributions and over 2,500 recurrent DNA sequence motifs. DeepMind reports best-in-class AVI performance on variant pathogenicity and rare disease benchmarks. Early users at the Broad Institute, University of Exeter, and Stowers Institute demonstrated rare-disease variant reprioritization and 22% more non-coding associations across 54,000+ UK Biobank genomes.
- AVI score merges AlphaGenome and AlphaMissense into one impact ranking covering coding and non-coding variants
- 1-petabyte dataset is over 30x larger than the AlphaFold Database
- Broad Institute collaborators validated a DNM1 splice variant linked to epileptic encephalopathy
- UK Biobank analysis of 54,000+ genomes surfaced 22% more non-coding associations
- Free academic portal and API now; commercial Google Cloud access coming soon; not clinically approved
From the original article
5 min read at marktechpost.com
DeepMind's AlphaGenome Atlas maps every single-letter change in the human genome with 1 impact score per variant. The post Google DeepMind Releases AlphaGenome Atlas With Precomputed Molecular Effect Predictions and AVI Scores for 9 Billion Human DNA Variants appeared first on MarkTechPost.
By Asif Razzaq · marktechpost.com
A short excerpt; the article and its images belong to the publisher. Summary, key facts and assessment above are AI-written from the article and can be wrong.